How GLP-1 medications actually work

The mechanism, in plain language

GLP-1 is a hormone your gut releases after eating. Medications like semaglutide mimic it: they slow how quickly your stomach empties and act on appetite centers in the brain, so you feel full sooner and stay full longer. Tirzepatide adds a second hormone pathway (GIP) on top.

The practical effect isn't willpower — it's that the constant background noise of food thoughts gets quieter. That's why these medications work where diets alone often don't: they change the biology the diet was fighting.

What the trials actually showed

In the STEP 1 trial (published in the New England Journal of Medicine, 2021), adults taking weekly semaglutide 2.4mg lost about 15% of body weight on average over 68 weeks, versus roughly 2% with placebo — both alongside lifestyle support. In SURMOUNT-1 (NEJM, 2022), the highest tirzepatide dose averaged around 20%.

Two honest caveats live inside those numbers: they're averages, not promises — individual results vary widely — and the trials paired medication with lifestyle changes, not instead of them.

Who shouldn't take them

Per FDA prescribing information, GLP-1 medications carry a boxed warning for medullary thyroid carcinoma — anyone with a personal or family history of it, or of MEN 2 syndrome, shouldn't take them. Pregnancy, a history of pancreatitis, and gastroparesis are also disqualifying or need careful in-person evaluation.

This is exactly why our intake asks about all of these before any provider review, and declines honestly when online treatment isn't the safe path.

What to expect if prescribed

Doses start low and step up over weeks to manage the most common side effects — nausea, constipation, fatigue — which usually ease as your body adjusts. Your provider sets the ramp and adjusts it based on how you actually respond.